Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: Is redifferentiation akin phenomenon a reality in neuroendocrine tumors?

Basu, SandipOstwal, V.2017-04-032017-04-032016Nuclear Medicine Communications, 2016. Vol. 37 (6): pp. 669-671http://hdl.handle.net/123456789/143093381 bytestext/htmlensomatostatin receptor68Ga-DOTATATE PET-CTeverolimus and capecitabine-temozolamideredifferentiation akin phenomenonneuroendocrine tumorsObservation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: Is redifferentiation akin phenomenon a reality in neuroendocrine tumors?Article